anciendaze
Senior Member (Voting Rights)
The assumption that results of covid-19 infection are binary, recover or die, has bothered me from day one. A recent blip in the news illustrates how politics, financial interests and possible liability complicate discussion and research on the subject of covid-19 sequelae.
CNN aired an interview with a doctor at Penn. State over possible myocarditis in infected athletes. This provoked a strong reaction to walk back the report. The evidence for this possibility was clearly inadequate, but I have to admit the university was probably motivated by alumni donors, loss of revenue and potential lawsuits to provide assurances they cannot yet back up.
Many of us have been told that we don't have the kind of inflammation pathologists can see in specimens, so our problems must be psychological. We now have multiple research papers showing signs of inflammation not apparent to eyeballs, following a presumed viral infection.
This is a reasonable question to ask concerning infection by SARS-CoV-2, but so far it has not been answered. Here's one example of the problems in research on the subject. If definitive answers require pathologist's samples from dead patients, or cardiac biopsies, it will be impossible to find such results in patients with mild infections. This is a catch-22 about obtaining solid data, not an assurance no such damage takes place.
We need better research.
CNN aired an interview with a doctor at Penn. State over possible myocarditis in infected athletes. This provoked a strong reaction to walk back the report. The evidence for this possibility was clearly inadequate, but I have to admit the university was probably motivated by alumni donors, loss of revenue and potential lawsuits to provide assurances they cannot yet back up.
Many of us have been told that we don't have the kind of inflammation pathologists can see in specimens, so our problems must be psychological. We now have multiple research papers showing signs of inflammation not apparent to eyeballs, following a presumed viral infection.
This is a reasonable question to ask concerning infection by SARS-CoV-2, but so far it has not been answered. Here's one example of the problems in research on the subject. If definitive answers require pathologist's samples from dead patients, or cardiac biopsies, it will be impossible to find such results in patients with mild infections. This is a catch-22 about obtaining solid data, not an assurance no such damage takes place.
We need better research.